These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3. Wang Y, Zhang JX, Du XX, Zhao L, Tian Q, Zhu LQ, Wang SH, Wang JZ. J Neurochem; 2008 Sep; 106(6):2364-74. PubMed ID: 18643871 [Abstract] [Full Text] [Related]
5. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X, Kosaraju J, Tam KY. Eur J Pharm Sci; 2017 Dec 15; 110():101-108. PubMed ID: 28359686 [Abstract] [Full Text] [Related]
6. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture. Li X, Lu F, Tian Q, Yang Y, Wang Q, Wang JZ. J Neural Transm (Vienna); 2006 Jan 15; 113(1):93-102. PubMed ID: 15959856 [Abstract] [Full Text] [Related]
10. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. Liu SJ, Zhang AH, Li HL, Wang Q, Deng HM, Netzer WJ, Xu H, Wang JZ. J Neurochem; 2003 Dec 15; 87(6):1333-44. PubMed ID: 14713290 [Abstract] [Full Text] [Related]
12. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N. Neurosci Lett; 2009 May 22; 455(3):191-4. PubMed ID: 19429119 [Abstract] [Full Text] [Related]
13. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro. Liu ZC, Fu ZQ, Song J, Zhang JY, Wei YP, Chu J, Han L, Qu N, Wang JZ, Tian Q. J Alzheimers Dis; 2012 May 22; 29(4):727-40. PubMed ID: 22460328 [Abstract] [Full Text] [Related]
18. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats. Peng JH, Zhang CE, Wei W, Hong XP, Pan XP, Wang JZ. Neuropharmacology; 2007 Jun 03; 52(7):1521-7. PubMed ID: 17434540 [Abstract] [Full Text] [Related]
19. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF, Mao QQ, Wu JC, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX. J Alzheimers Dis; 2014 Jun 03; 39(2):331-46. PubMed ID: 24164737 [Abstract] [Full Text] [Related]